Article Sidebar

PDF (Tiếng Việt)
Published: 2024-11-11
Abstract Views: 0
Views PDF (Tiếng Việt): 0
DOI: https://doi.org/10.52852/tcncyh.v183i10.2605
Issue
Vol. 183 No. 10 (2024)
Section
Các bài báo
How to Cite
Thái, N. Q., Thuỷ, N. T., & Hưng, Đỗ B. (2024). Diuretics in Ménière’s disease: A scoping review. Journal of Medical Research, 183(10), 431-440. https://doi.org/10.52852/tcncyh.v183i10.2605

Diuretics in Ménière’s disease: A scoping review

Nguyen Quang Thai, Nguyen Thi Thuy, Do Ba Hung

Main Article Content

Abstract

Ménière’s disease is characterized by recurrent episode of vertigo, hearing loss and tinnitus. Currently, there are many different methods of treating Ménière’s disease, of which using diuretics is considered effective. This review aims to evaluate the effectiveness of using diuretics to treat Ménière’s disease. A search of the electronic databases Pubmed, Web of Science, Cochrane library and Google Scholar was performed; . Of the 1073 studies identified, 14 eligible publications were included in the full-text analysis. We found 14 articles matching the selection criteria related to 736 patients with 3 main drug groups: Thiazides, Carbonic anhydrase (C.A) inhibitor diuretics, Osmotic diuretics and 2 groups of drugs are combined. We have conducted an analysis of the characteristics and therapeutic effectiveness of the above drugs. Although controversial, the review indicates that diuretic therapy in the treatment of Ménière's disease is an effective treatment for controlling vertigo and tinnitus, but hearing improvement still remains limited. The study also shows that oral diuretics are safe and convenient for long-term treatment of Ménière's disease.

Article Details

Keywords

Ménière’s disease, Diuretic, vertigo, hearing loss, tinnitus

References

1. Espinosa-Sanchez JM, Lopez-Escamez JA. Menière’s disease. In: Handbook of Clinical Neurology. Vol 137. Elsevier; 2016:257-277. doi:10.1016/B978-0-444-63437-5.00019-4.
2. Basura GJ, Adams ME, Monfared A, et al. Clinical Practice Guideline: Ménière’s Disease. Otolaryngol--head neck surg. 2020;162(S2). doi:10.1177/0194599820909438.
3. Ghavami Y, Haidar Y.M, Moshtaghi O, Lin H.W, Djalilian H.R. Evaluating Quality of Life in Patients With Meniere’s Disease Treated as Migraine. Annals of Otology. Rhinology & Laryngology. 2018; 127(12): 877-887.
4. Nevoux J, Franco-Vidal V, Bouccara D, et al. Diagnostic and therapeutic strategy in Meniere’s disease. Guidelines of the French Otothinolaryngology-Head and Neck Surgery Society (SFORL). European annals of otorhinolaryngology, head and neck diseases. 2017; 134(6): 441-444.
5. Crowson M.G, Patki A, Tucci D.L. A Systemic Review of Diuretics in the Medical Management of Meniere’s Disease. Otolaryngology - Head and Neck Surgery. 2016; 154(5):824-34.
6. Deelen G.W, Huizing E.H. Use of a diuretic (Dyazide) in the treatment of Meniere’s disease. A double-blind cross-over placebo-controlled study. ORL; journal for oto-rhino-laryngology and its related specialties. 1986; 48(5): 287-92.
7. Norell I and Stahle J. Treatment of Meniere’s Disease with Hydrochloro-Thiazide. Acta Oto-Laryngologica. 1962; 54: 447-456.
8. Varga G, Miriszlai E and Szabo L.Z. Experiences with acetazolamid therapy applied in our clinic to patients suffering from Meniere’s Disease for more than 8 years. The Journal of Laryngology & Otology. 1966; 80(3): 250-69.
9. Klockhoff I, Lindblom U. Meniére’s Disease and Hydrochlorothiazide (Dichlotride®) - A Critical Analysis of Symptoms and Therapeutic Effects. Acta Oto-Laryngologica. 1967;63(2-3):347-365. doi:10.3109/00016486709128769.
10. Klockhoff I, Lindblom U, Stahle J. Diuretic Treatment of Meniere Disease: Long-Term Results With Chlorthalidone. Archives of Otolaryngology - Head and Neck Surgery. 1974; 100(4):262-265. doi:10.1001/archotol.1974.00780040272004.
11. Kitahara M, Takeda T, Yazawa Y, Matsubara H, Kitano H. Treatment of Meniere’s Disease with Isosorbide. ORL. 1982; 44: 232-238.
12. Brookes G.B and Booth J.B. Oral acetazolamide in Meniere’s Disease. The Journal of Laryngology and Otology. 1984; 98: 1087-1095.
13. Santos P.M, Hall R.A, Snyder J.M. et al. Diuretic and diet effect on Meniere’s Disease evaluated by the 1985 Committee on Hearing and Equilibrium guideline. Otolaryngology - Head and Neck Surgery. 1993; 109(4): 680-9.
14. Kanda K, Watanabe Y, Shojaku H, Ito M, Mizukoshi K. Effects of Isosorbide in Patients with Meniere’s Disease. Acta Oto-Laryngologica. 1993; 504: 79-81.
15. Kakigi A, Takeda T, Saito H, Kataoka H. Effect of Isosorbide on Hearing Loss due to Endolymphatic Hydrops. Acta Oto-Laryngologica. 1995; 115(sup519): 223-226. doi:10.3109/00016489509121910.
16. Nozawa I, Nakayama H, Imamura S, Hisamatu K, Murakami Y.Efficacy of Long-Term Administration of Isosorbide for Meniere’s Disease. ORL. 1995; 57: 135-140.
17. Chung S.W, Cho C.H, Han G.C. Hearing and Dizziness in Patients with Definite Meniere’s Disease after the Long Term Use of Diuretics. The Journal of International Advanced Otology. 2010; 6(2): 188-194.
18. Khan B.H, Ahmed Z, Khan R.A. Effects of diuretic and vasodilator therapy in Meniere’s Disease. Biomedical. 2011; 27:114-118.
19. Scarpa A, Cassandro C, De Luca P, et al. Therapeutic role of intravenous glycerol for Meniere’s Disease Preliminary results. American Journal of Otolaryngology-Head and Neck Medicine and Surgery. 2020; 41(4): 102498.